A Prognostic Signature of Glycolysis-Related Long Noncoding RNAs for Molecular Subtypes in the Tumor Immune Microenvironment of Lung Adenocarcinoma

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. A Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• Schabath MB, Digiovanni J. Introduction to special issue: recent advances in mechanisms, prevention and treatment of lung cancer. Mol Carcinog. 2015;54:vi. doi:10.1002/mc.22337
   PubMed Web of Science ®Google Scholar
• Hirsch FR, Scagliotti GV, Mulshine JL, et al. Lung cancer: current therapies and new targeted treatments. Lancet. 2017;389:299–311. doi:10.1016/S0140-6736(16)30958-8
   PubMed Web of Science ®Google Scholar
• Person P. Otto warburg: “on the origin of cancer cells”. Oral Surg Oral Med Oral Pathol. 1957;10:412–421. doi:10.1016/0030-4220(57)90167-6
   Google Scholar
• Zhang L, Fu Y, Guo H. c-Myc-induced long non-coding RNA small nucleolar RNA host gene 7 regulates glycolysis in breast cancer. J Breast Cancer. 2019;22:533–547. doi:10.4048/jbc.2019.22.e54
   PubMed Web of Science ®Google Scholar
• Chang L, Fang S, Gu W. The molecular mechanism of metabolic remodeling in lung cancer. J Cancer. 2020;11:1403–1411. doi:10.7150/jca.31406
   PubMed Web of Science ®Google Scholar
• Mamede M, Higashi T, Kitaichi M, et al. [18F]FDG uptake and PCNA, Glut-1, and Hexokinase-II expressions in cancers and inflammatory lesions of the lung. Neoplasia. 2005;7:369–379. doi:10.1593/neo.04577
   PubMed Web of Science ®Google Scholar
• Li XB, Gu JD, Zhou QH. Review of aerobic glycolysis and its key enzymes - new targets for lung cancer therapy. Thorac Cancer. 2015;6:17–24. doi:10.1111/1759-7714.12148
   PubMed Web of Science ®Google Scholar
• Heiden M, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2015;324(5930):1029–1033. doi:10.1126/science.1160809
   Web of Science ®Google Scholar
• Fan WM, Lorkiewicz PK, Sellers K, Moseley H, Higashi RM, Lane AN. Stable isotope-resolved metabolomics and applications for drug development. Pharmacol Ther. 2012;133:366–391.
   PubMed Web of Science ®Google Scholar
• Jiang Z, Liu Z, Li M, Chen C, Wang X. Increased glycolysis correlates with elevated immune activity in tumor immune microenvironment. EBioMedicine. 2019;42:431–442. doi:10.1016/j.ebiom.2019.03.068
   PubMed Web of Science ®Google Scholar
• Scharping N, Menk A, Moreci R, et al. The tumor microenvironment represses T cell mitochondrial biogenesis to drive intratumoral T cell metabolic insufficiency and dysfunction. Immunity. 2016;45:701–703. doi:10.1016/j.immuni.2016.08.009
   PubMed Web of Science ®Google Scholar
• Rinn JL, Hy C. Genome regulation by long non-coding RNAs. 55th Annual Meeting of the American-Society-of-Hematology; 2013.
   Google Scholar
• Statello L, Guo CJ, Chen LL, Huarte M. Gene regulation by long non-coding RNAs and its biological functions. Mol Cell Biol. 2021;22(2):96–118. doi:10.1038/s41580-020-00315-9
   Web of Science ®Google Scholar
• Chen F, Chen J, Yang L, et al. Extracellular vesicle-packaged HIF-1α-stabilizing lncRNA from tumour-associated macrophages regulates aerobic glycolysis of breast cancer cells. Nat Cell Biol. 2019;21:498–510. doi:10.1038/s41556-019-0299-0
   PubMed Web of Science ®Google Scholar
• Lin A, Li C, Xing Z, et al. The LINK-A lncRNA activates normoxic HIF1α signalling in triple-negative breast cancer. Nat Cell Biol. 2016;18:213–224. doi:10.1038/ncb3295
   PubMed Web of Science ®Google Scholar
• Yang F, Zhang H, Mei Y, Wu M. Reciprocal regulation of HIF-1α and lincRNA-p21 modulates the Warburg effect - ScienceDirect. Mol Cell. 2014;53:88–100. doi:10.1016/j.molcel.2013.11.004
   PubMed Web of Science ®Google Scholar
• Zheng YL, Li L, Jia YX, et al. LINC01554-mediated glucose metabolism reprogramming suppresses tumorigenicity in hepatocellular carcinoma via downregulating PKM2 expression and inhibiting Akt/mTOR signaling pathway. Theranostics. 2019;9:796–810. doi:10.7150/thno.28992
   PubMed Web of Science ®Google Scholar
• Zhou M, Guo M, He D, et al. A potential signature of eight long non-coding RNAs predicts survival in patients with non-small cell lung cancer. J Transl Med. 2015;13:231. doi:10.1186/s12967-015-0556-3
   PubMed Web of Science ®Google Scholar
• Zhou M, Xu W, Yue X, et al. Relapse-related long non-coding RNA signature to improve prognosis prediction of lung adenocarcinoma. Oncotarget. 2016;7(20):29720–29738. doi:10.18632/oncotarget.8825
   PubMedGoogle Scholar
• Guo Y, Qu Z, Li D, et al. Identification of a prognostic ferroptosis-related lncRNA signature in the tumor microenvironment of lung adenocarcinoma. Cell Death Discov. 2021;7(1):190. doi:10.1038/s41420-021-00576-z
   PubMed Web of Science ®Google Scholar
• Lu L, Liu LP, Zhao QQ, Gui R, Zhao QY. Identification of a ferroptosis-related LncRNA signature as a novel prognosis model for lung adenocarcinoma. Front Oncol. 2021;11:675545. doi:10.3389/fonc.2021.675545
   PubMed Web of Science ®Google Scholar
• Sun J, Zhang Z, Bao S, et al. Identification of tumor immune infiltration-associated lncRNAs for improving prognosis and immunotherapy response of patients with non-small cell lung cancer. J Immunother Cancer. 2020;8(1):e000110. doi:10.1136/jitc-2019-000110
   PubMed Web of Science ®Google Scholar
• Jiang Y, Chen J, Ling J, et al. Construction of a Glycolysis-related long noncoding RNA signature for predicting survival in endometrial cancer. J Cancer. 2021;12:1431–1444. doi:10.7150/jca.50413
   PubMed Web of Science ®Google Scholar
• Kong XZ, Hu SS, Sun Z, et al. Regulation of aerobic glycolysis by long non-coding RNAs in cancer. Biochem Biophys Res Commun. 2016;479:28–32. doi:10.1016/j.bbrc.2016.09.007
   PubMed Web of Science ®Google Scholar
• Wang Y, Lu J, Wu Q. LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer. Mol Cancer. 2019;18(1):174. doi:10.1186/s12943-019-1105-0
   PubMed Web of Science ®Google Scholar
• Li JP, Li R, Liu X, et al. A seven immune-related lncRNAs model to increase the predicted value of lung adenocarcinoma. Front Oncol. 2020;10:560779. doi:10.3389/fonc.2020.560779
   PubMed Web of Science ®Google Scholar
• Liu Z, Mi M, Li X, Zheng X, Wu G, Zhang L. A lncRNA prognostic signature associated with immune infiltration and tumour mutation burden in breast cancer. J Cell Mol Med. 2020;24:12444–12456. doi:10.1111/jcmm.15762
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhou W, Ma S, et al. Identification of a glycolysis-related LncRNA signature to predict survival in diffuse glioma patients. Front Oncol. 2020;10:597877. doi:10.3389/fonc.2020.597877
   PubMed Web of Science ®Google Scholar
• Bai Y, Lin H, Chen J, Wu Y, Yu S. Identification of prognostic glycolysis-related lncRNA signature in tumor immune microenvironment of hepatocellular carcinoma. Front Mol Biosci. 2021;8:645084. doi:10.3389/fmolb.2021.645084
   PubMed Web of Science ®Google Scholar
• Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545–15550. doi:10.1073/pnas.0506580102
   PubMed Web of Science ®Google Scholar
• Wilkerson MD, Hayes DN. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics. 2010;26(12):1572–1573. doi:10.1093/bioinformatics/btq170
   PubMed Web of Science ®Google Scholar
• Gay CM, Stewart CA, Park EM. Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities. Cancer Cell. 2021;39(3):346–360.e347. doi:10.1016/j.ccell.2020.12.014
   PubMed Web of Science ®Google Scholar
• Yoshihara K, Shahmoradgoli M, Martínez E, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4:2612. doi:10.1038/ncomms3612
   PubMed Web of Science ®Google Scholar
• Gao J, Kwan PW, Shi D. Sparse kernel learning with LASSO and Bayesian inference algorithm. Neural Netw. 2010;23:257–264. doi:10.1016/j.neunet.2009.07.001
   PubMed Web of Science ®Google Scholar
• Li H, Zhao X, Jing W, Zong M, Yang H. Bioinformatics analysis of gene expression profile data to screen key genes involved in pulmonary sarcoidosis. Gene. 2017;596:98–104. doi:10.1016/j.gene.2016.09.037
   PubMed Web of Science ®Google Scholar
• Kuleshov MV, Jones MR, Rouillard AD, et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 2016;44:W90–W7. doi:10.1093/nar/gkw377
   PubMed Web of Science ®Google Scholar
• Bhattacharya S, Dunn P, Thomas CG, et al. ImmPort, toward repurposing of open access immunological assay data for translational and clinical research. Sci Data. 2018;5:180015. doi:10.1038/sdata.2018.15
   PubMed Web of Science ®Google Scholar
• Na SS, Aldonza MB, Sung HJ, et al. Stanniocalcin-2 (STC2): a potential lung cancer biomarker promotes lung cancer metastasis and progression. Biochim Biophys Acta. 2015;1854(6):668–676. doi:10.1016/j.bbapap.2014.11.002
   PubMed Web of Science ®Google Scholar
• Yu J, Liu TT, Liang LL, et al. Identification and validation of a novel glycolysis-related gene signature for predicting the prognosis in ovarian cancer. Cancer Cell Int. 2021;21(1). doi:10.1186/s12935-021-02045-0
   Web of Science ®Google Scholar
• Niu Y, Ma F, Huang W, et al. Long non-coding RNA TUG1 is involved in cell growth and chemoresistance of small cell lung cancer by regulating LIMK2b via EZH2. Mol Cancer. 2017;16(1):5. doi:10.1186/s12943-016-0575-6
   PubMed Web of Science ®Google Scholar
• Wu F, Zhou D, Cui Y, Shen G, Li Y, Wei F. Long non-coding RNA UCA1 modulates the glycolysis of cervical cancer cells by miR-493-5p/HK2. Int J Clin Exp Pathol. 2018;11(8):3943–3951.
   PubMed Web of Science ®Google Scholar
• Yin D, Hua L, Wang J, Liu Y, Li X. Long non-coding RNA DUXAP8 facilitates cell viability, migration, and glycolysis in non-small-cell lung cancer via regulating HK2 and LDHA by inhibition of miR-409-3p. Onco Targets Ther. 2020;13:7111–7123. doi:10.2147/OTT.S243542
   PubMed Web of Science ®Google Scholar
• Miao H, Chen D, Li R, et al. Identification of an immune-related six-long noncoding RNA signature as a novel prognosis biomarker for adenocarcinoma of lung. Biosci Rep. 2021;41(1). doi:10.1042/BSR20202444
   Web of Science ®Google Scholar
• Zhang B, Wang R, Li K, et al. An immune-related lncRNA expression profile to improve prognosis prediction for lung adenocarcinoma: from bioinformatics to clinical word. Front Oncol. 2021;11:671341. doi:10.3389/fonc.2021.671341
   PubMed Web of Science ®Google Scholar
• Wang RQ, Long XR, Ge CL, Zhang MY, Wang HY. Identification of a 4-lncRNA signature predicting prognosis of patients with non-small cell lung cancer: a multicenter study in China. J Transl Med. 2020;18:320. doi:10.1186/s12967-020-02485-8
   PubMed Web of Science ®Google Scholar
• Jafarzadeh M, Tavallaie M, Soltani BM, Hajipoor S, Hosseini SM. LncRNA HSPC324 plays role in lung development and tumorigenesis. Genomics. 2020;112:2615–2622. doi:10.1016/j.ygeno.2020.02.012
   PubMed Web of Science ®Google Scholar
• Shijie Z, Xiaoyun Q, Sun C, Zhuang G, Huaqi W. LncRNA NR2F2-AS1 promotes tumourigenesis through modulating BMI1 expression by targeting miR-320b in non-small cell lung cancer. J Cell Mol Med. 2018;23:2001–2011. doi:10.1111/jcmm.14102
   PubMed Web of Science ®Google Scholar
• Cabili MN, Trapnell C, Goff L, et al. Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev. 2011;25:1915–1927. doi:10.1101/gad.17446611
   PubMed Web of Science ®Google Scholar
• Zhao W, Luo J, Jiao S. Comprehensive characterization of cancer subtype associated long non-coding RNAs and their clinical implications. Sci Rep. 2014;4:6591. doi:10.1038/srep06591
   PubMed Web of Science ®Google Scholar
• Berger AC, Korkut A, Kanchi RS, et al. A comprehensive pan-cancer molecular study of gynecologic and breast cancers. Cancer Cell. 2018;33:690–705. doi:10.1016/j.ccell.2018.03.014
   PubMed Web of Science ®Google Scholar
• Murphy MB, Medvedev AE. Long noncoding RNAs as regulators of Toll-like receptor signaling and innate immunity. Plants (Basel). 2016;99:839–850.
   Google Scholar
• Sun C, Zhu W, Li S, Hu W, Li DJ. FOXC1-mediated LINC00301 facilitates tumor progression and triggers an immune-suppressing microenvironment in non-small cell lung cancer by regulating the HIF1α pathway. Genome Med. 2020;12:77. doi:10.1186/s13073-020-00773-y
   PubMed Web of Science ®Google Scholar
• Pei X, Wang X, Li H. LncRNA SNHG1 regulates the differentiation of Treg cells and affects the immune escape of breast cancer via regulating miR-448/IDO. Int J Biol Macromol. 2018;118(Pt A):24–30. doi:10.1016/j.ijbiomac.2018.06.033
   PubMed Web of Science ®Google Scholar
• Ho KH, Huang TW, Shih CM. Glycolysis-associated lncRNAs identify a subgroup of cancer patients with poor prognoses and a high-infiltration immune microenvironment. BMC Med. 2021;19(1):59. doi:10.1186/s12916-021-01925-6
   PubMed Web of Science ®Google Scholar